Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

PGNX News and Commentary

Caps

How do you think PGNX will perform against the market?

Add Stock to CAPS Watchlist

All Players

191 Outperform
23 Underperform
 

All-Star Players

33 Outperform
4 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top PGNX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

1760mill (43.35)
Submitted September 15, 2006

Drug for opioid-induced constipation has had very good trial results. FDA submission next year. Also discovered receptor HIV uses to enter cells, a potential blockbuster drug target, but still pretty far off.

zzlangerhans (99.84)
Submitted July 15, 2015

Progenics has acquired a cult following of sorts but I'm at a loss to understand the appeal. The main thing the company seems to have going is a recently-submitted NDA of Relistor subcutaneous injection for opioid-induced constipation in non-cancer… More

PGNX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about PGNX.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 12/7/2017 6:07:58 AM : Outperform Start Price: $5.68 PGNX Score: -0.42

expected rise at least 50% over the next 12 months based on consensus price targets supplied by FactSet

Recs

0
Member Avatar TMFang4apples (50.05) Submitted: 12/3/2016 2:28:17 PM : Outperform Start Price: $8.42 PGNX Score: -52.24

The tablet form of Relistor is taking off, providing Progenics with a high-margin revenue stream. With two fairly unique, wholly owned compounds nearing the finish line, and a cash runway that might be adequate to launch them, you're practically getting its mid-stage assets for free.

Recs

0
Member Avatar OKwarrior (41.12) Submitted: 11/9/2014 5:22:02 PM : Outperform Start Price: $5.40 PGNX Score: -24.93

volatile little biotech, always worth a trade and now it is in the bottom of it's cycle

Leaderboard

Find the members with the highest scoring picks in PGNX.

Score Leader

zzlangerhans

zzlangerhans (99.84) Score: +301.12

Survived an 86.45 negative score to regain the top spot here.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CNET0 36.31 10/15/2008 Underperform NS $10.79 -46.90% +180.48% +227.37 0 Comment
trossman 64.98 5/15/2009 Underperform 3M $5.37 +6.70% +203.03% +196.33 0 Comment
evgiotto 44.50 1/25/2008 Underperform 3W $18.31 -68.71% +105.08% +173.79 0 Comment
linklink1 < 20 4/25/2008 Underperform 3M $13.32 -56.98% +98.20% +155.18 0 Comment
rustydutch 58.22 12/21/2011 9/18/2012 Underperform 5Y $9.00 -36.33% +115.89% +152.22 0 Comment
htsigns < 20 11/12/2012 Outperform 5Y $1.67 +244.14% +92.79% +151.36 0 Comment
osleny 63.71 12/20/2011 Underperform 5Y $8.25 -30.55% +118.13% +148.67 0 Comment
speedhead 31.38 4/24/2008 Underperform 3Y $11.07 -48.24% +98.08% +146.32 0 Comment
GameEmag < 20 1/30/2012 Underperform 3M $9.54 -39.94% +104.21% +144.14 1 Comment
nhanhsong < 20 6/23/2010 Underperform 3M $5.62 +1.96% +143.08% +141.12 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPoisedTo < 20 12/21/2011 Underperform 5Y $8.41 -31.87% +115.05% +146.92 0 Comment
TrackBreanMurray 78.02 2/10/2011 Outperform NS $6.12 -6.37% +102.52% -108.89 0 Comment
TrackFBRCapitalM 88.31 7/2/2008 Underperform NS $14.95 +11.04% -2.82% -13.86 7/10/2008 @ $16.60 0 Comment
TrackLadenburg < 20 5/12/2008 Outperform NS $12.33 -53.53% +96.96% -150.48 0 Comment
TrackBreanMurray 78.02 3/12/2008 Outperform NS $5.04 +2.18% -41.87% +44.05 3/16/2009 @ $5.15 0 Comment
TrackBofASec 94.85 9/26/2007 Outperform NS $22.91 -74.99% +83.40% -158.39 0 Comment
TrackLazardCapit 78.98 3/7/2007 Outperform NS $23.31 -78.06% -4.96% -73.10 3/12/2008 @ $5.12 0 Comment
TrackPZK < 20 3/7/2007 Outperform NS $23.18 -58.37% -1.33% -57.04 4/17/2012 @ $9.65 0 Comment
TrackFBRCapitalM 88.31 2/14/2007 Outperform NS $30.11 -83.76% -8.74% -75.02 3/12/2008 @ $4.89 0 Comment
TrackRBCCapMkts 86.96 1/29/2007 Outperform NS $30.02 -80.91% +98.94% -179.86 0 Comment
TrackBroadpointAmTech < 20 11/6/2006 Outperform NS $26.00 -62.88% +0.80% -63.69 4/17/2012 @ $9.65 0 Comment
TrackPiperJaff 85.03 8/22/2006 Outperform NS $21.33 -73.14% +118.56% -191.70 0 Comment
TrackJimCramer 85.08 4/26/2006 Outperform 3W $22.59 -74.63% +118.06% -192.70 0 Comment

Featured Broker Partners